Ariad Pharmaceuticals Inc fka ARIA

[zuize]

Ariad was never going to have and will never have a 16 bil mc.
Despite what some here might believe.

comparing revenue number and products pipeline between the twos, if someone willing to offer $16 billion for PCYC, then $4 billion (or $21/share) is a reasonable figure for ARIA

Another very interesting is short interests continue to increase even PCYC stock price is getting doubled in the last 3 months. I just don't understand their logic for not willing to cover their short positions. Given PCYC traded under $100/share 6 months ago, those 5.3 million shares shorted translated into a loss of nearly $700 millions at the stock price today.


2/13/2015 5,345,467 792,949 6.741249
1/30/2015 5,188,727 1,048,770 4.947440
1/15/2015 5,179,457 1,245,682 4.157929
12/31/2014 5,162,701 784,103 6.584213
12/15/2014 4,502,061 569,150 7.910148
11/28/2014 4,657,993 515,858 9.029603
11/14/2014 4,878,928 832,443 5.860975
10/31/2014 5,250,367 865,013 6.069697
10/15/2014 5,059,629 801,412 6.313393
9/30/2014 4,808,013 700,831 6.860446
9/15/2014 5,170,579 964,126 5.362970
8/29/2014 5,025,248 708,901 7.088787
8/15/2014 5,480,343 978,201 5.602471
7/31/2014 6,475,147 1,320,990 4.901738
7/15/2014 6,315,801 1,107,827 5.701072
6/30/2014 5,624,008 968,719 5.805613
6/13/2014 5,699,387 1,197,661 4.758765
5/30/2014 4,708,763 1,479,049 3.183642
5/15/2014 4,405,934 1,909,568 2.307294
4/30/2014 3,101,212 1,394,566 2.223783

Read more: http://www.nasdaq.com/symbol/pcyc/short-interest#ixzz3So2Ms1HL